Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
Treatment with low-molecular-weight heparins is very common in clinical practice. Exceptionally, some patients develop hepatitis within a few days of starting treatment, and rapid discontinuation of the drug is decisive to avoid chronification.
Main Authors: | Velasco de Cos Guillermo, Sánchez-Molina Acosta Isabel, Iturralde Ros Marta, Maiztegi Azpitarte Ainhoa, Moyano Martinez Ana |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-11-01
|
Series: | Advances in Laboratory Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/almed-2021-0048 |
Similar Items
-
Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
by: A. R. M. Misthaq, et al.
Published: (2019-10-01) -
Hepatotoxicidad colestásica asociada a tratamiento con enoxaparina
by: Velasco de Cos Guillermo, et al.
Published: (2021-11-01) -
A cholestatic type of hepatitis A in a child
by: Sjamsul Arief, et al.
Published: (2001-12-01) -
Enoxaparin-induced retroperitoneal haematoma in patients with renal insufficiency
by: M Fernández-Ruiz, et al.
Published: (2010-02-01) -
Bullous hemorrhagic dermatosis induced by enoxaparin
by: Isa An, et al.
Published: (2017-01-01)